Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma
Various clinical and experimental observations detected an immunological host defense in cutaneous melanoma. In order to investigate the prognostic value of leukocyte effector mechanisms, we examined the presence of different subsets of leukocytes in tumor samples of 58 patients diagnosed with prima...
Gespeichert in:
Veröffentlicht in: | Cancer Immunology, Immunotherapy Immunotherapy, 2008-01, Vol.57 (1), p.97-106 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 106 |
---|---|
container_issue | 1 |
container_start_page | 97 |
container_title | Cancer Immunology, Immunotherapy |
container_volume | 57 |
creator | Hillen, Femke Baeten, Coen I. M. van de Winkel, Anouk Creytens, David van der Schaft, Daisy W. J. Winnepenninckx, Véronique Griffioen, Arjan W. |
description | Various clinical and experimental observations detected an immunological host defense in cutaneous melanoma. In order to investigate the prognostic value of leukocyte effector mechanisms, we examined the presence of different subsets of leukocytes in tumor samples of 58 patients diagnosed with primary cutaneous melanoma. The presence of T lymphocytes, cytotoxic T lymphocytes, B lymphocytes, CD16+ cells and macrophages was correlated to Breslow depth. A significantly higher amount of several subsets of leukocytes was found in samples with a more progressed tumor stage and survival analysis demonstrated that a higher amount of T lymphocytes and CD16+ cells was associated with a short survival. The amount of FOXP3+ regulatory T lymphocytes did not correlate with survival, nevertheless, it correlated with the amount of total infiltrate. In contrast, analysis of the expression of CD69, a marker for activated lymphocytes, demonstrated that patients with a higher amount of CD69+ lymphocytes had a better survival. In addition, a new parameter for aggressiveness of melanoma, tumor cell plasticity [i.e., the presence of periodic acid Schiff’s (PAS) reagent positive loops], also predicted short survival and a trend of a higher amount of tumor infiltrating leukocytes in tumors with PAS positive loops was observed. These findings demonstrate that leukocyte infiltration and the presence of PAS loops is a sign of tumor aggressiveness and may have prognostic value. |
doi_str_mv | 10.1007/s00262-007-0353-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11030822</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1376376451</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-84d446b29ad26623abc45c7d7b4c2ee7355da07e4c4829ec01453a81944c94c73</originalsourceid><addsrcrecordid>eNp1kV2L1TAQhoMo7tnVH-CNBEHvqvlq2l6JLLoKB7zR6zAnnR6ztskxSRfOvzelZVcFr2bIPDOZd15CXnD2ljPWvEuMCS2qklZM1rLqHpEdV7K8tDV_THZMKlY1jKkLcpnSbUkE67qn5II3mgkh6h0Je5x_BnvOSJ0f3JgjZBc8Bd_TPE8hUovjSE8jpOysy2cKEekJIkyYMSYaBgrHY8SU3B36Esoceopugnimds7gMcyJTjiCDxM8I08GGBM-3-IV-f7p47frz9X-682X6w_7ytaC56pVvVL6IDrohdZCwsGq2jZ9c1BWIDayrntgDSqrWtGhZVzVElreKWU7ZRt5Rd6vc0_zYcLeoi_KRrMtZgI483fFux_mGO4M50yyVogy4c02IYZfM6ZsJpeWY6yKTLlr22gtC_jqH_A2zNEXdUZwWXOmdVsgvkI2hpQiDvercGYWM81qplnSxUzTlZ6Xf2p46NjcK8DrDYBkYRwieOvSPSeWq2ihCidWLpWSP2J82PD_v_8G2XC5fg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>213510668</pqid></control><display><type>article</type><title>Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma</title><source>MEDLINE</source><source>SpringerLink Journals</source><source>PubMed Central</source><creator>Hillen, Femke ; Baeten, Coen I. M. ; van de Winkel, Anouk ; Creytens, David ; van der Schaft, Daisy W. J. ; Winnepenninckx, Véronique ; Griffioen, Arjan W.</creator><creatorcontrib>Hillen, Femke ; Baeten, Coen I. M. ; van de Winkel, Anouk ; Creytens, David ; van der Schaft, Daisy W. J. ; Winnepenninckx, Véronique ; Griffioen, Arjan W.</creatorcontrib><description>Various clinical and experimental observations detected an immunological host defense in cutaneous melanoma. In order to investigate the prognostic value of leukocyte effector mechanisms, we examined the presence of different subsets of leukocytes in tumor samples of 58 patients diagnosed with primary cutaneous melanoma. The presence of T lymphocytes, cytotoxic T lymphocytes, B lymphocytes, CD16+ cells and macrophages was correlated to Breslow depth. A significantly higher amount of several subsets of leukocytes was found in samples with a more progressed tumor stage and survival analysis demonstrated that a higher amount of T lymphocytes and CD16+ cells was associated with a short survival. The amount of FOXP3+ regulatory T lymphocytes did not correlate with survival, nevertheless, it correlated with the amount of total infiltrate. In contrast, analysis of the expression of CD69, a marker for activated lymphocytes, demonstrated that patients with a higher amount of CD69+ lymphocytes had a better survival. In addition, a new parameter for aggressiveness of melanoma, tumor cell plasticity [i.e., the presence of periodic acid Schiff’s (PAS) reagent positive loops], also predicted short survival and a trend of a higher amount of tumor infiltrating leukocytes in tumors with PAS positive loops was observed. These findings demonstrate that leukocyte infiltration and the presence of PAS loops is a sign of tumor aggressiveness and may have prognostic value.</description><identifier>ISSN: 0340-7004</identifier><identifier>EISSN: 1432-0851</identifier><identifier>DOI: 10.1007/s00262-007-0353-9</identifier><identifier>PMID: 17602225</identifier><identifier>CODEN: CIIMDN</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Angiogenesis ; Antigens, CD - biosynthesis ; Antigens, Differentiation, T-Lymphocyte - biosynthesis ; Antineoplastic agents ; Biological and medical sciences ; Cancer ; Cancer Research ; Dermatology ; Female ; Humans ; Immunohistochemistry ; Immunology ; Immunotherapy ; Lectins, C-Type ; Leukocytes ; Lymphocyte Activation - immunology ; Lymphocyte Subsets - immunology ; Lymphocyte Subsets - metabolism ; Lymphocytes ; Lymphocytes, Tumor-Infiltrating - immunology ; Lymphocytes, Tumor-Infiltrating - metabolism ; Macrophages - immunology ; Male ; Medical prognosis ; Medical sciences ; Medicine ; Medicine & Public Health ; Melanoma ; Melanoma - blood supply ; Melanoma - immunology ; Melanoma - pathology ; Metastasis ; Neoplasm Staging ; Neovascularization, Pathologic ; Oncology ; Original ; Original Article ; Patients ; Pharmacology. Drug treatments ; Prognosis ; Skin Neoplasms - blood supply ; Skin Neoplasms - immunology ; Skin Neoplasms - pathology ; Survival Analysis ; Tumors ; Tumors of the skin and soft tissue. Premalignant lesions</subject><ispartof>Cancer Immunology, Immunotherapy, 2008-01, Vol.57 (1), p.97-106</ispartof><rights>Springer-Verlag 2007</rights><rights>2008 INIST-CNRS</rights><rights>Springer-Verlag 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521t-84d446b29ad26623abc45c7d7b4c2ee7355da07e4c4829ec01453a81944c94c73</citedby><cites>FETCH-LOGICAL-c521t-84d446b29ad26623abc45c7d7b4c2ee7355da07e4c4829ec01453a81944c94c73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11030822/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11030822/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,41467,42536,51298,53770,53772</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20145624$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17602225$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hillen, Femke</creatorcontrib><creatorcontrib>Baeten, Coen I. M.</creatorcontrib><creatorcontrib>van de Winkel, Anouk</creatorcontrib><creatorcontrib>Creytens, David</creatorcontrib><creatorcontrib>van der Schaft, Daisy W. J.</creatorcontrib><creatorcontrib>Winnepenninckx, Véronique</creatorcontrib><creatorcontrib>Griffioen, Arjan W.</creatorcontrib><title>Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma</title><title>Cancer Immunology, Immunotherapy</title><addtitle>Cancer Immunol Immunother</addtitle><addtitle>Cancer Immunol Immunother</addtitle><description>Various clinical and experimental observations detected an immunological host defense in cutaneous melanoma. In order to investigate the prognostic value of leukocyte effector mechanisms, we examined the presence of different subsets of leukocytes in tumor samples of 58 patients diagnosed with primary cutaneous melanoma. The presence of T lymphocytes, cytotoxic T lymphocytes, B lymphocytes, CD16+ cells and macrophages was correlated to Breslow depth. A significantly higher amount of several subsets of leukocytes was found in samples with a more progressed tumor stage and survival analysis demonstrated that a higher amount of T lymphocytes and CD16+ cells was associated with a short survival. The amount of FOXP3+ regulatory T lymphocytes did not correlate with survival, nevertheless, it correlated with the amount of total infiltrate. In contrast, analysis of the expression of CD69, a marker for activated lymphocytes, demonstrated that patients with a higher amount of CD69+ lymphocytes had a better survival. In addition, a new parameter for aggressiveness of melanoma, tumor cell plasticity [i.e., the presence of periodic acid Schiff’s (PAS) reagent positive loops], also predicted short survival and a trend of a higher amount of tumor infiltrating leukocytes in tumors with PAS positive loops was observed. These findings demonstrate that leukocyte infiltration and the presence of PAS loops is a sign of tumor aggressiveness and may have prognostic value.</description><subject>Angiogenesis</subject><subject>Antigens, CD - biosynthesis</subject><subject>Antigens, Differentiation, T-Lymphocyte - biosynthesis</subject><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Cancer</subject><subject>Cancer Research</subject><subject>Dermatology</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Immunology</subject><subject>Immunotherapy</subject><subject>Lectins, C-Type</subject><subject>Leukocytes</subject><subject>Lymphocyte Activation - immunology</subject><subject>Lymphocyte Subsets - immunology</subject><subject>Lymphocyte Subsets - metabolism</subject><subject>Lymphocytes</subject><subject>Lymphocytes, Tumor-Infiltrating - immunology</subject><subject>Lymphocytes, Tumor-Infiltrating - metabolism</subject><subject>Macrophages - immunology</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Melanoma</subject><subject>Melanoma - blood supply</subject><subject>Melanoma - immunology</subject><subject>Melanoma - pathology</subject><subject>Metastasis</subject><subject>Neoplasm Staging</subject><subject>Neovascularization, Pathologic</subject><subject>Oncology</subject><subject>Original</subject><subject>Original Article</subject><subject>Patients</subject><subject>Pharmacology. Drug treatments</subject><subject>Prognosis</subject><subject>Skin Neoplasms - blood supply</subject><subject>Skin Neoplasms - immunology</subject><subject>Skin Neoplasms - pathology</subject><subject>Survival Analysis</subject><subject>Tumors</subject><subject>Tumors of the skin and soft tissue. Premalignant lesions</subject><issn>0340-7004</issn><issn>1432-0851</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kV2L1TAQhoMo7tnVH-CNBEHvqvlq2l6JLLoKB7zR6zAnnR6ztskxSRfOvzelZVcFr2bIPDOZd15CXnD2ljPWvEuMCS2qklZM1rLqHpEdV7K8tDV_THZMKlY1jKkLcpnSbUkE67qn5II3mgkh6h0Je5x_BnvOSJ0f3JgjZBc8Bd_TPE8hUovjSE8jpOysy2cKEekJIkyYMSYaBgrHY8SU3B36Esoceopugnimds7gMcyJTjiCDxM8I08GGBM-3-IV-f7p47frz9X-682X6w_7ytaC56pVvVL6IDrohdZCwsGq2jZ9c1BWIDayrntgDSqrWtGhZVzVElreKWU7ZRt5Rd6vc0_zYcLeoi_KRrMtZgI483fFux_mGO4M50yyVogy4c02IYZfM6ZsJpeWY6yKTLlr22gtC_jqH_A2zNEXdUZwWXOmdVsgvkI2hpQiDvercGYWM81qplnSxUzTlZ6Xf2p46NjcK8DrDYBkYRwieOvSPSeWq2ihCidWLpWSP2J82PD_v_8G2XC5fg</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Hillen, Femke</creator><creator>Baeten, Coen I. M.</creator><creator>van de Winkel, Anouk</creator><creator>Creytens, David</creator><creator>van der Schaft, Daisy W. J.</creator><creator>Winnepenninckx, Véronique</creator><creator>Griffioen, Arjan W.</creator><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20080101</creationdate><title>Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma</title><author>Hillen, Femke ; Baeten, Coen I. M. ; van de Winkel, Anouk ; Creytens, David ; van der Schaft, Daisy W. J. ; Winnepenninckx, Véronique ; Griffioen, Arjan W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-84d446b29ad26623abc45c7d7b4c2ee7355da07e4c4829ec01453a81944c94c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Angiogenesis</topic><topic>Antigens, CD - biosynthesis</topic><topic>Antigens, Differentiation, T-Lymphocyte - biosynthesis</topic><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Cancer</topic><topic>Cancer Research</topic><topic>Dermatology</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Immunology</topic><topic>Immunotherapy</topic><topic>Lectins, C-Type</topic><topic>Leukocytes</topic><topic>Lymphocyte Activation - immunology</topic><topic>Lymphocyte Subsets - immunology</topic><topic>Lymphocyte Subsets - metabolism</topic><topic>Lymphocytes</topic><topic>Lymphocytes, Tumor-Infiltrating - immunology</topic><topic>Lymphocytes, Tumor-Infiltrating - metabolism</topic><topic>Macrophages - immunology</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Melanoma</topic><topic>Melanoma - blood supply</topic><topic>Melanoma - immunology</topic><topic>Melanoma - pathology</topic><topic>Metastasis</topic><topic>Neoplasm Staging</topic><topic>Neovascularization, Pathologic</topic><topic>Oncology</topic><topic>Original</topic><topic>Original Article</topic><topic>Patients</topic><topic>Pharmacology. Drug treatments</topic><topic>Prognosis</topic><topic>Skin Neoplasms - blood supply</topic><topic>Skin Neoplasms - immunology</topic><topic>Skin Neoplasms - pathology</topic><topic>Survival Analysis</topic><topic>Tumors</topic><topic>Tumors of the skin and soft tissue. Premalignant lesions</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hillen, Femke</creatorcontrib><creatorcontrib>Baeten, Coen I. M.</creatorcontrib><creatorcontrib>van de Winkel, Anouk</creatorcontrib><creatorcontrib>Creytens, David</creatorcontrib><creatorcontrib>van der Schaft, Daisy W. J.</creatorcontrib><creatorcontrib>Winnepenninckx, Véronique</creatorcontrib><creatorcontrib>Griffioen, Arjan W.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer Immunology, Immunotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hillen, Femke</au><au>Baeten, Coen I. M.</au><au>van de Winkel, Anouk</au><au>Creytens, David</au><au>van der Schaft, Daisy W. J.</au><au>Winnepenninckx, Véronique</au><au>Griffioen, Arjan W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma</atitle><jtitle>Cancer Immunology, Immunotherapy</jtitle><stitle>Cancer Immunol Immunother</stitle><addtitle>Cancer Immunol Immunother</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>57</volume><issue>1</issue><spage>97</spage><epage>106</epage><pages>97-106</pages><issn>0340-7004</issn><eissn>1432-0851</eissn><coden>CIIMDN</coden><abstract>Various clinical and experimental observations detected an immunological host defense in cutaneous melanoma. In order to investigate the prognostic value of leukocyte effector mechanisms, we examined the presence of different subsets of leukocytes in tumor samples of 58 patients diagnosed with primary cutaneous melanoma. The presence of T lymphocytes, cytotoxic T lymphocytes, B lymphocytes, CD16+ cells and macrophages was correlated to Breslow depth. A significantly higher amount of several subsets of leukocytes was found in samples with a more progressed tumor stage and survival analysis demonstrated that a higher amount of T lymphocytes and CD16+ cells was associated with a short survival. The amount of FOXP3+ regulatory T lymphocytes did not correlate with survival, nevertheless, it correlated with the amount of total infiltrate. In contrast, analysis of the expression of CD69, a marker for activated lymphocytes, demonstrated that patients with a higher amount of CD69+ lymphocytes had a better survival. In addition, a new parameter for aggressiveness of melanoma, tumor cell plasticity [i.e., the presence of periodic acid Schiff’s (PAS) reagent positive loops], also predicted short survival and a trend of a higher amount of tumor infiltrating leukocytes in tumors with PAS positive loops was observed. These findings demonstrate that leukocyte infiltration and the presence of PAS loops is a sign of tumor aggressiveness and may have prognostic value.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>17602225</pmid><doi>10.1007/s00262-007-0353-9</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0340-7004 |
ispartof | Cancer Immunology, Immunotherapy, 2008-01, Vol.57 (1), p.97-106 |
issn | 0340-7004 1432-0851 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11030822 |
source | MEDLINE; SpringerLink Journals; PubMed Central |
subjects | Angiogenesis Antigens, CD - biosynthesis Antigens, Differentiation, T-Lymphocyte - biosynthesis Antineoplastic agents Biological and medical sciences Cancer Cancer Research Dermatology Female Humans Immunohistochemistry Immunology Immunotherapy Lectins, C-Type Leukocytes Lymphocyte Activation - immunology Lymphocyte Subsets - immunology Lymphocyte Subsets - metabolism Lymphocytes Lymphocytes, Tumor-Infiltrating - immunology Lymphocytes, Tumor-Infiltrating - metabolism Macrophages - immunology Male Medical prognosis Medical sciences Medicine Medicine & Public Health Melanoma Melanoma - blood supply Melanoma - immunology Melanoma - pathology Metastasis Neoplasm Staging Neovascularization, Pathologic Oncology Original Original Article Patients Pharmacology. Drug treatments Prognosis Skin Neoplasms - blood supply Skin Neoplasms - immunology Skin Neoplasms - pathology Survival Analysis Tumors Tumors of the skin and soft tissue. Premalignant lesions |
title | Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T08%3A04%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Leukocyte%20infiltration%20and%20tumor%20cell%20plasticity%20are%20parameters%20of%20aggressiveness%20in%20primary%20cutaneous%20melanoma&rft.jtitle=Cancer%20Immunology,%20Immunotherapy&rft.au=Hillen,%20Femke&rft.date=2008-01-01&rft.volume=57&rft.issue=1&rft.spage=97&rft.epage=106&rft.pages=97-106&rft.issn=0340-7004&rft.eissn=1432-0851&rft.coden=CIIMDN&rft_id=info:doi/10.1007/s00262-007-0353-9&rft_dat=%3Cproquest_pubme%3E1376376451%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=213510668&rft_id=info:pmid/17602225&rfr_iscdi=true |